Capital Performance Advisors’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-71
Closed -$1.14K 2473
2024
Q3
$1.14K Buy
+71
New +$1.14K ﹤0.01% 1844